Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/111181/1/sim6445.pd
Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combine...
International audienceBACKGROUND: Tools for differentiating aggressive and indolent prostate carcino...
In the field of survival analysis, we often encounter the situation where a fraction of the study su...
The dynamics of tumor burden, secreted proteins or other biomarkers over time, is often used to eval...
For monitoring patients treated for prostate cancer, Prostate Specific Antigen (PSA) is measured per...
The dynamics of tumor burden, secreted proteins or other biomarkers over time, is often used to eval...
International audienceIn metastatic castration-resistant prostate cancer (mCRPC) clinical trials, th...
International audienceJoint modelling is increasingly popular for investigating the relationship bet...
Treatment evaluation for metastatic Castration-Resistant Prostate Cancer (mCRPC) relies on time-to-d...
Prostate specific antigen (PSA) is a common biomarker used to aid detection of prostate cancer (PCa)...
The effect of a targeted agent on a cancer patients clinical outcome putatively is mediated through ...
Many medical investigations generate both longitudinal and survival data. Methods for the combined a...
Prostate Specific Antigen (PSA) is a biochemical marker used to monitor prostate cancer following tr...
Summary: The effect of a targeted agent on a cancer patient’s clinical outcome putatively is mediate...
Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combine...
International audienceBACKGROUND: Tools for differentiating aggressive and indolent prostate carcino...
In the field of survival analysis, we often encounter the situation where a fraction of the study su...
The dynamics of tumor burden, secreted proteins or other biomarkers over time, is often used to eval...
For monitoring patients treated for prostate cancer, Prostate Specific Antigen (PSA) is measured per...
The dynamics of tumor burden, secreted proteins or other biomarkers over time, is often used to eval...
International audienceIn metastatic castration-resistant prostate cancer (mCRPC) clinical trials, th...
International audienceJoint modelling is increasingly popular for investigating the relationship bet...
Treatment evaluation for metastatic Castration-Resistant Prostate Cancer (mCRPC) relies on time-to-d...
Prostate specific antigen (PSA) is a common biomarker used to aid detection of prostate cancer (PCa)...
The effect of a targeted agent on a cancer patients clinical outcome putatively is mediated through ...
Many medical investigations generate both longitudinal and survival data. Methods for the combined a...
Prostate Specific Antigen (PSA) is a biochemical marker used to monitor prostate cancer following tr...
Summary: The effect of a targeted agent on a cancer patient’s clinical outcome putatively is mediate...
Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combine...
International audienceBACKGROUND: Tools for differentiating aggressive and indolent prostate carcino...
In the field of survival analysis, we often encounter the situation where a fraction of the study su...
DOI
Add to ORKG